Digital tools to support cancer patients, caregivers, and oncology professionals

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project will deploy the Althea platform to adult and pediatric patients (older than 12), survivors, caregivers, family members, and oncology healthcare professionals at multiple European sites. The study will collect demographic, clinical, and professional variables such as age, gender, cancer type and stage, time since diagnosis, professional role, and prior oncology or psycho-oncology training to characterize end users. Participants will use the platform and provide feedback through structured questionnaires, usage metrics, and interviews to inform usability and feature refinement. The aim is to optimize the platform for clinical and psychosocial support rather than to test a therapeutic intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

HEALTHCARE PROFESSIONALS:

* Healthcare professionals actually working in oncology and/or psychooncology;
* Teachers of paediatric cancer patients.

ADULT POPULATION:

* Patients with a current or previous cancer diagnosis
* Adequate language proficiency,
* Able to provide informed consent;

PAEDIATRIC POPULATION:

* Older than 12 years of age;
* Patients with a current or previous cancer diagnosis;
* Adequate language proficiency;
* Legal guardians of paediatric cancer patients able to provide informed consent.

CAREGIVERS:

* Caregivers and/or family members of cancer patients who lived or assist the loved ones with a current or previous cancer diagnosis in the cancer journey;
* Adequate language proficiency;
* Able to provide informed consent;
* Caregivers and/or family members of paediatric cancer patients under 12 years of age.

Exclusion Criteria:

* Healthcare professionals with limited oncology patient contact;
* Insufficient knowledge of the local language;
* Severe cognitive impairment, and/or mental disorders that prohibited their participation in the study or inadequate verbal skills that may render them incapable of informed consent (as evaluated by the clinician);
* Inability to understand the study materials (as evaluated by the clinician);
* Physical or psychological impairment that prohibits their participation in focus groups (as evaluated by the clinician).

Where it's running

• Centre François Baclesse
  Caen, France Recruiting
• Saarland University
  Homburg, Germany Not yet recruiting
• European Institute of Oncology
  Milan, Italy, Italy Not yet recruiting
• National Cancer Institute
  Vilnius, Lithuania Not yet recruiting
• Catalan Institute of Oncology
  Barcelona, Spain Not yet recruiting

Study contacts

• Principal investigator: Gabriella Pravettoni, MD — European Institute of Oncology
• Study coordinator: Gabriella Pravettoni, MD
• Email: gabriella.pravettoni@ieo.it
• Phone: +390257489731

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using deep learning and Raman spectroscopy for early cancer diagnosis

  This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.

  Recruiting at 4 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Nanchang, Jiangxi and 3 other locations · NCT06822413

• Imaging metabolic processes in the body using Carbon-13 pyruvate

  This study is testing a new type of MRI using a special substance to see if it can help us understand how the body processes energy in people with heart problems and healthy volunteers without using harmful radiation.

  Recruiting Phase 2 National Heart Centre Singapore · Singapore · NCT06645691

• Evaluating a blood test for early cancer detection in military veterans

  This study is testing a new blood test to see if it can help find different types of cancer early in military veterans.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT06523868

• STEPwise program promoting ingenious online supportive solutions for cancer-related fatigue

  This trial tests three French-language digital programs to see if they reduce bothersome cancer-related fatigue in adults with cancer who report moderate to severe fatigue.

  Recruiting Gustave Roussy, Cancer Campus, Grand Paris · Villejuif · NCT06505590

• Understanding cancer through genomic profiling and analytics

  This study is trying to understand the genetic features of different types of cancer in people from a community healthcare system to improve screening and treatment options.

  Recruiting at 6 sites Avera McKennan Hospital & University Health Center · Marshall, Minnesota and 5 other locations · NCT05142033

• Risk-based lung cancer screening in COPD patients using ML and clinical models

  This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.

  Recruiting Vejle Hospital · Vejle, Region Syddanmark · NCT07848815

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.